• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双酰胺基膦酸酯前药的效率。

Efficiency of bis-amidate phosphonate prodrugs.

作者信息

Lentini Nicholas A, Huang Xueting, Schladetsch Megan A, Hsiao Chia-Hung Christine, Wiemer David F, Wiemer Andrew J

机构信息

Department of Chemistry, University of Iowa, Iowa City, IA 52242-1294, United States.

Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT 06269-3092, United States.

出版信息

Bioorg Med Chem Lett. 2022 Jun 15;66:128724. doi: 10.1016/j.bmcl.2022.128724. Epub 2022 Apr 8.

DOI:10.1016/j.bmcl.2022.128724
PMID:35405283
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10245299/
Abstract

Bis-amidate derivatives have been viewed as attractive phosphonate prodrug forms because of their straightforward synthesis, lack of phosphorus stereochemistry, plasma stability and nontoxic amino acid metabolites. However, the efficiency of bis-amidate prodrug forms is unclear, as prior studies on this class of prodrugs have not evaluated their activation kinetics. Here, we synthetized a small panel of bis-amidate prodrugs of butyrophilin ligands as potential immunotherapy agents. These compounds were examined relative to other prodrug forms delivering the same payload for their stability in plasma and cell lysate, their ability to stimulate T cell proliferation in human PBMCs, and their activation kinetics in a leukemia co-culture model of T cell cytokine production. The bis-amidate prodrugs demonstrate high plasma stability and improved cellular phosphoantigen activity relative to the free phosphonic acid. However, the efficiency of bis-amidate activation is low relative to other prodrugs that contain at least one ester such as aryl-amidate, aryl-acyloxyalkyl ester, and bis-acyloxyalkyl ester forms. Therefore, bis-amidate prodrugs do not drive rapid cellular payload accumulation and they would be more useful for payloads in which slower, sustained-release kinetics are preferred.

摘要

双酰胺衍生物因其合成简单、不存在磷立体化学、血浆稳定性以及无毒氨基酸代谢产物等特点,被视为具有吸引力的膦酸酯前药形式。然而,双酰胺前药形式的效率尚不清楚,因为此前对这类前药的研究并未评估其活化动力学。在此,我们合成了一小批作为潜在免疫治疗药物的嗜乳脂蛋白配体双酰胺前药。相对于递送相同有效载荷的其他前药形式,对这些化合物在血浆和细胞裂解物中的稳定性、在人外周血单核细胞中刺激T细胞增殖的能力以及在T细胞细胞因子产生的白血病共培养模型中的活化动力学进行了研究。与游离膦酸相比,双酰胺前药表现出高血浆稳定性和改善的细胞磷酸抗原活性。然而,相对于其他含有至少一个酯的前药,如芳基酰胺、芳基酰氧基烷基酯和双酰氧基烷基酯形式,双酰胺活化的效率较低。因此,双酰胺前药不会促使细胞有效载荷快速积累,它们对于更倾向于较慢、缓释动力学的有效载荷会更有用。

相似文献

1
Efficiency of bis-amidate phosphonate prodrugs.双酰胺基膦酸酯前药的效率。
Bioorg Med Chem Lett. 2022 Jun 15;66:128724. doi: 10.1016/j.bmcl.2022.128724. Epub 2022 Apr 8.
2
Stability and Efficiency of Mixed Aryl Phosphonate Prodrugs.混合芳基膦酸酯前药的稳定性和效率。
ChemMedChem. 2019 Sep 4;14(17):1597-1603. doi: 10.1002/cmdc.201900344. Epub 2019 Jul 24.
3
Diester Prodrugs of a Phosphonate Butyrophilin Ligand Display Improved Cell Potency, Plasma Stability, and Payload Internalization.膦酸酯丁酰苯丙氨酸配体的二酯前药提高了细胞效力、血浆稳定性和有效载荷内化。
J Med Chem. 2023 Nov 23;66(22):15309-15325. doi: 10.1021/acs.jmedchem.3c01358. Epub 2023 Nov 7.
4
Mixed Aryl Phosphonate Prodrugs of a Butyrophilin Ligand.一种嗜乳脂蛋白配体的混合芳基膦酸酯前药。
ACS Med Chem Lett. 2017 Aug 9;8(9):914-918. doi: 10.1021/acsmedchemlett.7b00245. eCollection 2017 Sep 14.
5
Amidate prodrugs of 9-[2-(phosphonomethoxy)ethyl]adenine as inhibitors of adenylate cyclase toxin from Bordetella pertussis.9-[2-(膦酸甲氧基)乙基]腺嘌呤的酰胺前药作为百日咳博德特氏菌的腺苷酸环化酶毒素抑制剂。
Antimicrob Agents Chemother. 2014;58(2):664-71. doi: 10.1128/AAC.01685-13. Epub 2013 Oct 21.
6
Potent double prodrug forms of synthetic phosphoantigens.强效双前药形式的合成磷酸抗原。
Bioorg Med Chem. 2020 Oct 1;28(19):115666. doi: 10.1016/j.bmc.2020.115666. Epub 2020 Jul 29.
7
A novel and efficient one-pot synthesis of symmetrical diamide (bis-amidate) prodrugs of acyclic nucleoside phosphonates and evaluation of their biological activities.一种新型高效的无环核苷膦酸对称二酰胺(双酰胺酯)前药的一锅合成及生物活性评价。
Eur J Med Chem. 2011 Sep;46(9):3748-54. doi: 10.1016/j.ejmech.2011.05.040. Epub 2011 May 23.
8
A luciferase lysis assay reveals in vivo malignant cell sensitization by phosphoantigen prodrugs.荧光素酶裂解测定法揭示了磷酸抗原前药对体内恶性细胞的致敏作用。
Biochem Pharmacol. 2019 Dec;170:113668. doi: 10.1016/j.bcp.2019.113668. Epub 2019 Oct 16.
9
Phosphonamidate Prodrugs of a Butyrophilin Ligand Display Plasma Stability and Potent Vγ9 Vδ2 T Cell Stimulation.丁酰膦酸酯前药的结合蛋白配体具有稳定的血浆特性和有效的 Vγ9 Vδ2 T 细胞刺激作用。
J Med Chem. 2018 Oct 11;61(19):8658-8669. doi: 10.1021/acs.jmedchem.8b00655. Epub 2018 Sep 26.
10
Enhanced Plasma Stability and Potency of Aryl/Acyloxy Prodrugs of a BTN3A1 Ligand.BTN3A1配体的芳基/酰氧基前药的血浆稳定性和效力增强
ACS Med Chem Lett. 2024 Sep 25;15(10):1771-1777. doi: 10.1021/acsmedchemlett.4c00371. eCollection 2024 Oct 10.

引用本文的文献

1
Enhanced Plasma Stability and Potency of Aryl/Acyloxy Prodrugs of a BTN3A1 Ligand.BTN3A1配体的芳基/酰氧基前药的血浆稳定性和效力增强
ACS Med Chem Lett. 2024 Sep 25;15(10):1771-1777. doi: 10.1021/acsmedchemlett.4c00371. eCollection 2024 Oct 10.
2
Phosphonodiamidate prodrugs of phosphoantigens (ProPAgens) exhibit potent Vγ9/Vδ2 T cell activation and eradication of cancer cells.磷酸抗原的膦酸二酰胺前药(ProPAgens)表现出强大的Vγ9/Vδ2 T细胞激活作用并能根除癌细胞。
RSC Med Chem. 2024 Jun 3;15(7):2462-2473. doi: 10.1039/d4md00208c. eCollection 2024 Jul 17.
3
Cytotoxicity of phosphoramidate, bis-amidate and cycloSal prodrug metabolites against tumour and normal cells.氨基磷酸酯、双酰胺和环Sal前药代谢物对肿瘤细胞和正常细胞的细胞毒性。
RSC Med Chem. 2024 Apr 18;15(6):1973-1981. doi: 10.1039/d4md00115j. eCollection 2024 Jun 19.
4
Diester Prodrugs of a Phosphonate Butyrophilin Ligand Display Improved Cell Potency, Plasma Stability, and Payload Internalization.膦酸酯丁酰苯丙氨酸配体的二酯前药提高了细胞效力、血浆稳定性和有效载荷内化。
J Med Chem. 2023 Nov 23;66(22):15309-15325. doi: 10.1021/acs.jmedchem.3c01358. Epub 2023 Nov 7.

本文引用的文献

1
Synthesis and Metabolism of BTN3A1 Ligands: Studies on Diene Modifications to the Phosphoantigen Scaffold.BTN3A1配体的合成与代谢:磷抗原支架的二烯修饰研究
ACS Med Chem Lett. 2022 Jan 27;13(2):164-170. doi: 10.1021/acsmedchemlett.1c00408. eCollection 2022 Feb 10.
2
Ligand-induced interactions between butyrophilin 2A1 and 3A1 internal domains in the HMBPP receptor complex.配体诱导的 HMBPP 受体复合物中丁酸蛋白 2A1 和 3A1 内部结构域之间的相互作用。
Cell Chem Biol. 2022 Jun 16;29(6):985-995.e5. doi: 10.1016/j.chembiol.2022.01.004. Epub 2022 Jan 25.
3
Halogen-Dance-Based Synthesis of Phosphonomethoxyethyl (PME) Substituted 2-Aminothiazoles as Potent Inhibitors of Bacterial Adenylate Cyclases.基于卤素-舞蹈反应的磷甲氧基乙基(PME)取代 2-氨基噻唑的合成,作为细菌腺苷酸环化酶的有效抑制剂。
ChemMedChem. 2022 Jan 5;17(1):e202100568. doi: 10.1002/cmdc.202100568. Epub 2021 Oct 22.
4
Targeting butyrophilins for cancer immunotherapy.针对丁酸蛋白用于癌症免疫治疗。
Trends Immunol. 2021 Aug;42(8):670-680. doi: 10.1016/j.it.2021.06.002. Epub 2021 Jul 9.
5
Self-activation of Vγ9Vδ2 T cells by exogenous phosphoantigens involves TCR and butyrophilins.外源性磷酸抗原通过 TCR 和 BTN 蛋白激活 Vγ9Vδ2 T 细胞。
Cell Mol Immunol. 2021 Aug;18(8):1861-1870. doi: 10.1038/s41423-021-00720-w. Epub 2021 Jun 28.
6
Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens.γ9δ2 T 细胞可同时杀伤肿瘤细胞并交叉呈递肿瘤抗原。
Front Immunol. 2021 Jun 2;12:645131. doi: 10.3389/fimmu.2021.645131. eCollection 2021.
7
Synthesis and Metabolism of BTN3A1 Ligands: Studies on Modifications of the Allylic Alcohol.BTN3A1配体的合成与代谢:烯丙醇修饰的研究
ACS Med Chem Lett. 2020 Dec 4;12(1):136-142. doi: 10.1021/acsmedchemlett.0c00586. eCollection 2021 Jan 14.
8
Characterization of ascites- and tumor-infiltrating γδ T cells reveals distinct repertoires and a beneficial role in ovarian cancer.腹水和肿瘤浸润 γδ T 细胞的特征分析揭示了其在卵巢癌中的独特特征和有益作用。
Sci Transl Med. 2021 Jan 20;13(577). doi: 10.1126/scitranslmed.abb0192.
9
γδ T cells in tissue physiology and surveillance.γδ T 细胞在组织生理学和监视中的作用。
Nat Rev Immunol. 2021 Apr;21(4):221-232. doi: 10.1038/s41577-020-00452-4. Epub 2020 Oct 14.
10
Potent double prodrug forms of synthetic phosphoantigens.强效双前药形式的合成磷酸抗原。
Bioorg Med Chem. 2020 Oct 1;28(19):115666. doi: 10.1016/j.bmc.2020.115666. Epub 2020 Jul 29.